Functioning neuroendocrine tumor of pancreas

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:506060
Who is this for?
Show terms as
3Active trials10Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

A functioning neuroendocrine tumor of the pancreas (also called a functional pancreatic NET, or F-pNET) is a rare type of tumor that grows in the pancreas — a gland in your belly that helps with digestion and controls blood sugar. What makes these tumors special is that they are 'functioning,' meaning they actively release hormones into your bloodstream. Depending on which hormone is released, the tumor has a specific name — for example, insulinoma (releases insulin), gastrinoma (releases gastrin), glucagonoma, VIPoma, or somatostatinoma. These extra hormones cause a wide range of symptoms that can affect many parts of the body. Because these tumors produce hormones, symptoms often appear before the tumor itself is found. For example, an insulinoma causes dangerously low blood sugar, while a gastrinoma causes severe stomach ulcers. This can make diagnosis tricky, and many patients see multiple doctors before getting the right answer. Treatment depends on the type and stage of the tumor. Surgery to remove the tumor is the main goal when possible and can be curative. When surgery is not an option, doctors use medications to control hormone levels and slow tumor growth. FDA-approved treatments include somatostatin analogs like octreotide (Sandostatin) and lanreotide (Somatuline), as well as everolimus (Afinitor) and sunitinib (Sutent) for advanced cases. Peptide receptor radionuclide therapy (PRRT) with lutetium-177 dotatate (Lutathera) is also approved for certain patients. With proper treatment, many people live for years with this condition.

Also known as:

Key symptoms:

Low blood sugar episodes (shakiness, sweating, confusion) — mainly with insulinomaSevere or recurring stomach ulcers — mainly with gastrinomaPersistent diarrheaSkin rash, especially a red, blistering rash on the legs and face — mainly with glucagonomaUnexplained weight lossAbdominal pain or discomfortNausea and vomitingWatery diarrhea and low potassium levels — mainly with VIPomaHigh blood sugar (diabetes-like symptoms) — mainly with glucagonoma or somatostatinomaFlushing or redness of the faceFatigue and weaknessGallstones — mainly with somatostatinomaHeartburn or acid reflux that does not respond to usual treatments

Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Adult

Begins in adulthood (age 18 or older)

Orphanet ↗NORD ↗

FDA & Trial Timeline

4 events
Dec 2021Lutetium 177Lu-Edotreotide Versus Best Standard of Care in Well-differentiated Aggressive Grade-2 and Grade-3 GastroEnteroPancreatic NeuroEndocrine Tumors (GEP-NETs) - COMPOSE

ITM Solucin GmbH — PHASE3

TrialACTIVE NOT RECRUITING
Oct 2018Testing Cabozantinib in Patients With Advanced Pancreatic Neuroendocrine and Carcinoid Tumors

National Cancer Institute (NCI) — PHASE3

TrialACTIVE NOT RECRUITING
Feb 2017Efficacy and Safety of 177Lu-edotreotide PRRT in GEP-NET Patients

ITM Solucin GmbH — PHASE3

TrialACTIVE NOT RECRUITING
Oct 2000Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders

Mayo Clinic

TrialRECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

No FDA-approved treatments are currently listed for Functioning neuroendocrine tumor of pancreas.

3 clinical trialsare actively recruiting — trials can provide access to cutting-edge therapies.

View clinical trials →

Clinical Trials

3 recruitingView all trials with filters →
Phase 32 trials
Testing Cabozantinib in Patients With Advanced Pancreatic Neuroendocrine and Carcinoid Tumors
Phase 3
Active
PI: Jennifer A Chan (Alliance for Clinical Trials in Oncology) · Sites: Anchorage, Alaska; Kingman, Arizona +432 more · Age: 1899 yrs
Lutetium 177Lu-Edotreotide Versus Best Standard of Care in Well-differentiated Aggressive Grade-2 and Grade-3 GastroEnteroPancreatic NeuroEndocrine Tumors (GEP-NETs) - COMPOSE
Phase 3
Active
· Sites: Palo Alto, California; Aurora, Colorado +40 more · Age: 1899 yrs
Other1 trial
Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders
Actively Recruiting
PI: Shounak Majumder, MD (Mayo Clinic) · Sites: Phoenix, Arizona; Jacksonville, Florida +1 more · Age: 1899 yrs

Specialists

10 foundView all specialists →
JC
Jennifer A Chan
Specialist
PI on 1 active trial103 Functioning neuroendocrine tumor of pancreas publications
AP
Alberto Larghi, PhD
ROME, ITALY
Specialist
PI on 1 active trial
OP
Olov Norlén, MD, PhD
Specialist
PI on 1 active trial
SP
Stefano Partelli, MD, PhD
Specialist
PI on 1 active trial
AS
Andreas Selberherr
Specialist
PI on 1 active trial

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Functioning neuroendocrine tumor of pancreas.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Functioning neuroendocrine tumor of pancreasForum →

No community posts yet. Be the first to share your experience with Functioning neuroendocrine tumor of pancreas.

Start the conversation →

Latest news about Functioning neuroendocrine tumor of pancreas

No recent news articles for Functioning neuroendocrine tumor of pancreas.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.What type of functioning pancreatic NET do I have, and which hormone is it producing?,Has the tumor spread, and am I a candidate for surgery?,Should I be tested for a hereditary condition like MEN1, and should my family members be tested?,What medications will I need, and what are the side effects?,Am I eligible for PRRT (Lutathera) or any clinical trials?,How often will I need imaging and blood tests to monitor the tumor?,What dietary changes should I make to manage my symptoms?

Common questions about Functioning neuroendocrine tumor of pancreas

What is Functioning neuroendocrine tumor of pancreas?

A functioning neuroendocrine tumor of the pancreas (also called a functional pancreatic NET, or F-pNET) is a rare type of tumor that grows in the pancreas — a gland in your belly that helps with digestion and controls blood sugar. What makes these tumors special is that they are 'functioning,' meaning they actively release hormones into your bloodstream. Depending on which hormone is released, the tumor has a specific name — for example, insulinoma (releases insulin), gastrinoma (releases gastrin), glucagonoma, VIPoma, or somatostatinoma. These extra hormones cause a wide range of symptoms tha

At what age does Functioning neuroendocrine tumor of pancreas typically begin?

Typical onset of Functioning neuroendocrine tumor of pancreas is adult. Age of onset can vary across affected individuals.

Are there clinical trials for Functioning neuroendocrine tumor of pancreas?

Yes — 3 recruiting clinical trials are currently listed for Functioning neuroendocrine tumor of pancreas on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.

Which specialists treat Functioning neuroendocrine tumor of pancreas?

10 specialists and care centers treating Functioning neuroendocrine tumor of pancreas are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.